Credit Suisse’s Achaogen Inc AKAO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-116,806
Closed -$53K 4340
2019
Q1
$53K Buy
+116,806
New +$123K ﹤0.01% 3898
2018
Q4
Sell
-18,229
Closed -$73K 4078
2018
Q3
$73K Sell
18,229
-6,881
-27% -$41.6K ﹤0.01% 3730
2018
Q2
$218K Sell
25,110
-8,263
-25% -$101K ﹤0.01% 3736
2018
Q1
$432K Buy
33,373
+3,806
+13% +$43.2K ﹤0.01% 3429
2017
Q4
$317K Sell
29,567
-18,644
-39% -$234K ﹤0.01% 3611
2017
Q3
$769K Buy
48,211
+3,261
+7% +$62.1K ﹤0.01% 3281
2017
Q2
$977K Buy
44,950
+32,519
+262% +$742K ﹤0.01% 2712
2017
Q1
$314K Buy
+12,431
New +$255K ﹤0.01% 3502
2015
Q3
Sell
-21,907
Closed -$132K 4603
2015
Q2
$132K Buy
+21,907
New +$136K ﹤0.01% 4335

Other funds holding AKAO

Credit Suisse's AKAO Position: Q2 2019 in Review

Credit Suisse sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 116,806 shares — an estimated $53K sold.

Credit Suisse first reported a position in AKAO in Q2 2015 and held it in 9 quarters. The position peaked at $977K in Q2 2017. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.

  • Credit Suisse reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
  • Credit Suisse sold 116,806 Achaogen Inc shares in Q2 2019, an estimated $53K.
  • Credit Suisse first reported a position in Achaogen Inc in Q2 2015 and held it in 9 quarters.
  • Credit Suisse's Achaogen Inc position peaked at $977K in Q2 2017.
  • 8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.

Based on Credit Suisse's 13F filing for Q2 2019, filed 14 Aug 2019.